Vista Pharmaceuticals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 0.03 | 2.51 | 1.65 |
| Operating Expense | 7.06 | 5.42 | 4.90 |
| Net Profit | -5.86 | -2.32 | -2.59 |
| Net Profit Margin | -19,533.33% | -92.43% | -156.97% |
| Earning Per Share | -0.91 | -0.41 | -0.42 |
| EBIDTA | -5.12 | -1.95 | -2.21 |
| Effective Tax Rate | -0% | -0% | -0% |
Particulars
Mar 2026
Revenue0.03
Operating Expense7.06
Net Profit-5.86
Net Profit Margin-19,533.33
Earning Per Share-0.91
EBIDTA-5.12
Effective Tax Rate-0
